Metronidazole Benzoate Oral Suspension from Japan
Pediatric metronidazole benzoate oral suspension (200mg/5ml) treats protozoal infections in children. HTS 3004.90.92.09 covers this salt form in measured doses for prophylactic and therapeutic retail use.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Include pediatric exclusivity data and shake-well labeling compliance
• Validate beyond-use dating for reconstituted suspensions
• Test for preservative efficacy per USP <51> before import clearance